| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/19/2001 | EP1133516A1 Chromosome 17p-linked prostate cancer susceptibility gene |
| 09/19/2001 | EP1133514A1 Method for the electrochemical detection of nucleic acid oligomer hybrids |
| 09/19/2001 | EP1133513A1 Multidomain polynucleotide molecular sensors |
| 09/19/2001 | EP1133310A2 Artery- and vein-specific proteins and uses therefor |
| 09/19/2001 | EP1133304A2 Use of nucleotides and dinucleotides for thetreatment of vaginal dryness and vulvar pain |
| 09/19/2001 | CN1313891A Methods of monitoring disease states and therapies using gene expression profiles |
| 09/19/2001 | CN1313387A Method for expression various proteins in plants with converted genes |
| 09/19/2001 | CN1313386A Kuhseng agglutinin and its zoophobous and disease-resistant coding gene and application |
| 09/19/2001 | CN1313336A Polypeptide-jhuman telomeric repetitive sequence bindin 14 and polynucleotide for coding it |
| 09/19/2001 | CN1313335A Polypeptide-human uterin globin 40 and polynucleotide for coding it |
| 09/19/2001 | CN1313332A Polypeptide-human NTF2 associated protein 16 and polynucleotide for coding it |
| 09/19/2001 | CN1313331A Polypeptide-human plasminogen activator inhibitor 2-27 and polynucleotide for coding it |
| 09/19/2001 | CN1313323A Polypeptide-human amyloid glucoprotein 23 and polynucleotide for coding it |
| 09/19/2001 | CN1313318A Human protein able to suppress growth of cancer cells and its coding sequence |
| 09/19/2001 | CN1313317A Human protein able to suppress growth of cancer cells and its coding sequence |
| 09/19/2001 | CN1313316A Human protein able to suppress growth of cancer cells and its coding squence |
| 09/19/2001 | CN1313315A Human protein able to suppress growth of cancer cells and its coding sequence |
| 09/19/2001 | CN1313314A Polypeptide-human signal recognition factor 12 and polynucleotide for coding it |
| 09/19/2001 | CN1313313A Polypeptide-human CDC4 analogous protein 12 and polynucleotide for coding it |
| 09/19/2001 | CN1313311A Polypeptide-human NRG3-22 and polynucleotide for coding it |
| 09/19/2001 | CN1313309A Polypeptide-human GAPa protein 9 and polynucleotide for coding it |
| 09/19/2001 | CN1313305A Polypeptide-human guanine intertransform factor 17 and polynucleotide for coding it |
| 09/19/2001 | CN1313303A Polypeptide-human nucleolar phospholation protein P130-17 and polynucleotide for coding it |
| 09/19/2001 | CN1313298A Human protein able to suppress growth of cancer cells and its coding sequence |
| 09/19/2001 | CN1313297A Human protein able to suppress growth of cancer cells and its coding sequence |
| 09/19/2001 | CN1313296A Polypeptide-zinc finger protein 62 and polynucleotide for coding it |
| 09/19/2001 | CN1313294A Polypeptide-mTERF-42 and polynucleotide for coding it |
| 09/18/2001 | US6291669 Support system for synthesizing oligomers includes a hydroxyl-containing compound bound to support by a disiloxyl linkage; efficient oligonculeotide synthesis |
| 09/18/2001 | US6291649 Anti-bodies binding adhesin-derived antigens |
| 09/18/2001 | US6291642 Mammalian cell cycle protein |
| 09/18/2001 | US6291438 Antiviral anticancer poly-substituted phenyl derivatized oligoribonucleotides and methods for their use |
| 09/18/2001 | US6291248 Isolating preferential nucleotide sequences in sample; incubate nucleotide sequences with silicon carbide and recover bound nucleotide sequences |
| 09/18/2001 | US6291206 BMP receptor proteins |
| 09/18/2001 | US6291199 Human phosphodiesterase type IVC, and its production and use |
| 09/18/2001 | US6291188 Metallic solid supports modified with nucleic acids |
| 09/18/2001 | US6291186 Method for screening for unknown organisms |
| 09/18/2001 | US6291184 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex |
| 09/18/2001 | US6291183 A plurality of oligonucleotide linker molecules are attached on a planar solid support, photoremovable groups react with terminal ends of oligonucleotides, substrates exposed to light activate binding at selected areas; peptide synthesis |
| 09/18/2001 | US6291169 Hapten derivatized capture membrane and diagnostic assays using such membrane |
| 09/18/2001 | US6291166 Irreversibly capturing rna or dna using highly electropositive solid phases matrices, as a means for aqueous washes, buffer changes and volume reduction during procedure; for direct analysis of single or double stranded nucleic acid |
| 09/18/2001 | US6290965 DNA encoding human papillomavirus type 6A |
| 09/18/2001 | CA2145182C Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 09/18/2001 | CA1341292C The manufacture and expression of consensus human leukocyte interferon |
| 09/13/2001 | WO2001067129A2 Epoxide polymer surfaces |
| 09/13/2001 | WO2001066802A1 SYSTEMS AND METHODS TO QUANTIFY AND AMPLIFY BOTH SIGNALING AND PROBES FOR cDNA CHIPS AND GENES EXPRESSION MICROARRAYS |
| 09/13/2001 | WO2001066798A2 Random truncation and amplification of nucleic acid |
| 09/13/2001 | WO2001066556A1 5-pyrimidine-containing nucleic acids and reversible ligation method by using the same |
| 09/13/2001 | WO2001066554A2 Solid phase synthesis method and reagent |
| 09/13/2001 | WO2001011010A3 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
| 09/13/2001 | WO2000041731A9 Reverse gene therapy |
| 09/13/2001 | WO1997041130A3 Sulfurization of phosphorus-containing compounds |
| 09/13/2001 | US20010021772 Vascular endothelial growth factor |
| 09/13/2001 | US20010021768 Protein |
| 09/13/2001 | US20010021526 Immortal rho degrees cell line; undifferentiated cells for drug screening; alzheimers, huntington's disease, myoclonic epilepsy lactic acidosis and stroke (MELAS); myoclonic epilepsy ragged red fiber (MERRF) |
| 09/13/2001 | US20010021506 The functionalized silicon compound containing one or more derivatizable functional group selected from the group consisting of hydroxyl, amino, amido, carboxyl, thio, halo and sulfonate, and one or more acativated silicon group |
| 09/13/2001 | CA2401320A1 Random truncation and amplification of nucleic acid |
| 09/13/2001 | CA2398280A1 Epoxide polymer surfaces |
| 09/12/2001 | EP1132467A2 Novel creatine amidinohydrolase, production thereof and use thereof |
| 09/12/2001 | EP1132091A1 Treatment for diabetes |
| 09/12/2001 | EP1131332A1 Antisense modulation of inhibitor-kappa b kinase-beta expression |
| 09/12/2001 | EP1131153A1 A method for reproducing molecular arrays |
| 09/12/2001 | EP1131090A2 Method of using pon-1 to decrease atheroma formation |
| 09/12/2001 | EP1042407B1 Rigidized trimethine cyanine dyes |
| 09/12/2001 | EP0881485A4 Method for detecting a biologically active substance in a liquid to be analysed and device for realising the same |
| 09/12/2001 | EP0804452B1 Recombinant c140 receptor, its agonists and antagonists |
| 09/12/2001 | EP0631635B1 Comparative genomic hybridization (cgh) |
| 09/12/2001 | EP0586474B1 Peptide nucleic acids |
| 09/12/2001 | CN1312858A Bactericidal/permeability-increasing protein delation analogs |
| 09/12/2001 | CN1312723A Compound and method for diagnosis of tuberculosis |
| 09/12/2001 | CN1312289A Human gonadotropin-releasing hormone 23 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312286A Human FD14 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312285A Human zinc finger protein 15 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312277A Human telomere repetitive sequence binding protein 13 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312266A Human FD9 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312255A Ribosome S3 protein 9 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/11/2001 | US6288221 Methods of synthesis of halogen base-modified oligonucleotides and subsequent labeling with a metal-catalyzed reaction |
| 09/11/2001 | US6288220 Nucleotide sequence layout for analysis of preferential particles in sample; for the diagnosis of genetic disorders |
| 09/11/2001 | US6288042 Administering to treat human t-cell leukemia/lymphoma virus |
| 09/11/2001 | US6288035 Administering polypeptide as antitumor agent to treat melanoma; medical diagnosis |
| 09/11/2001 | US6287853 Genetically engineered escherichia plasmid; marking antibiotic resistance; artificial chromosomes; genetic mapping |
| 09/11/2001 | US6287850 Bioarray chip reaction apparatus and its manufacture |
| 09/11/2001 | US6287821 Nucleotide having cleavable linking group, spacer linking group, and reporter molecule attached at 3' position; reporter molecule has greater fluorescence when unattached from nucleotide; sensitive amplification of signal |
| 09/11/2001 | US6287820 Noninvasive diagnostic method by analyzing urine sample for nucleic acid from cells outside of urinary tract that have crossed the kidney barrier and contains sequence indicative of cancer |
| 09/11/2001 | US6287817 Administering fusion protein of single chain fv molecule against transcytotic receptor linked to therapeutic protein; delivers protein to epithelial cell; treatment of cystic fibrosis |
| 09/11/2001 | US6287780 Compounds for mass spectrometry comprising nucleic acid bases and aryl ether mass markers |
| 09/11/2001 | US6287768 Polymeric arrays and methods for their use in binding assays |
| 09/11/2001 | US6287765 Synthetic heteropolymers, oligonucleotide molecule capable of specifically binding to nonoligonucleotide; template-directed molecular assembly and device integration; drug delivery systems, sensors, switches, transducers |
| 09/11/2001 | US6287762 Purification of a triple helix formation with an immobilized oligonucleotide |
| 09/11/2001 | US6287759 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 09/11/2001 | US6287756 Methods for determining presence of cancer in a sample by determining expression of an SSX gene |
| 09/11/2001 | US6287571 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier |
| 09/11/2001 | US6287559 Cloning and recombinant production of vespid venom hyaluronidases, and immunological therapies based thereon |
| 09/11/2001 | US6287517 Active electrodes especially adapted for electrophoretic transport of nucleic acids, their hybridization and analysis |
| 09/11/2001 | CA2021528C Muteins of human erythropoietin, the preparation thereof and the use thereof |
| 09/07/2001 | WO2001064958A2 Modified oligonucleotides for mismatch discrimination |
| 09/07/2001 | WO2001064942A1 Protein scaffolds for antibody mimics and other binding proteins |
| 09/07/2001 | WO2001064903A2 Novel human transferase proteins and polynucleotides encoding the same |
| 09/07/2001 | WO2001064856A2 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding |
| 09/07/2001 | WO2001064808A1 Coating system based on pyranosyl nucleic acids (p-na) |
| 09/07/2001 | WO2001064706A1 Antisense modulation of e2f transcription factor 1 expression |